Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

The imaging artificial intelligence developer Quibim has raised $50 million in venture capital funding, to support its work ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

BRUSSELS: Artificial intelligence (AI), biotech and affordable clean energy will be the focus of a European Union (EU) drive ...